Faeth Therapeutics (FTH) Payables (2020 - 2026)
Faeth Therapeutics' (FTH) quarterly Payables came in at $9.0 million in Q1 2026, up 280.92% YoY from $2.4 million in Q1 2025, and up 1203.63% on a QoQ basis from $689000.0 in Q4 2025.
Faeth Therapeutics (FTH) Payables (2020 - 2026) Analysis & Trends
Faeth Therapeutics (FTH) has 7 years of Payables data on file, last reported at $9.0 million in Q1 2026.
- Quarterly Payables rose 280.92% year-over-year to $9.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $9.0 million (up 280.92% YoY) and the FY2025 annual result came in at $689000.0, down 44.79% from the prior year.
- Payables rose to $9.0 million in Q1 2026, from $689000.0 in the prior quarter.
- In the past five years, Payables ranged from a high of $9.0 million in Q1 2026 to a low of $351000.0 in Q2 2025.
- A 5-year average of $2.8 million and a median of $2.3 million in 2023 frame the typical range for Payables.
- Annual changes were most pronounced in 2023 — Payables slumped 87.19% — and 2026, when it surged 280.92%.
- Tracing FTH's Payables over 5 years: stood at $4.5 million in 2022, then tumbled by 87.19% to $573000.0 in 2023, then soared by 117.8% to $1.2 million in 2024, then tumbled by 44.79% to $689000.0 in 2025, then jumped by 1203.63% to $9.0 million in 2026.
- The last three Payables figures came in at $9.0 million (Q1 2026), $689000.0 (Q4 2025), and $1.4 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 429.50 Mn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 1.16 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 1.52 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 167.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 470.30 Mn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 108.02 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 428.93 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 35.57 Mn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 622.65 Mn |
| 10 | Faeth Therapeutics | 180.89 Mn | 180.89 Mn | - | 7.57 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 7.57 Mn |
| Mar 31, 2026 | 8.98 Mn |
| Dec 31, 2025 | 689,000.00 |
| Sep 30, 2025 | 1.41 Mn |
| Jun 30, 2025 | 351,000.00 |
| Mar 31, 2025 | 2.36 Mn |
| Dec 31, 2024 | 1.25 Mn |
| Sep 30, 2024 | 1.68 Mn |
| Jun 30, 2024 | 1.65 Mn |
| Mar 31, 2024 | 2.00 Mn |
| Dec 31, 2023 | 573,000.00 |
| Sep 30, 2023 | 2.73 Mn |
| Jun 30, 2023 | 2.33 Mn |
| Mar 31, 2023 | 4.72 Mn |
| Dec 31, 2022 | 4.47 Mn |
| Sep 30, 2022 | 4.66 Mn |
| Jun 30, 2022 | 2.42 Mn |
| Mar 31, 2022 | 5.10 Mn |
| Dec 31, 2021 | 2.46 Mn |
| Sep 30, 2021 | 3.61 Mn |